Manning Paul B 13D and 13G filings for Verrica Pharmaceuticals Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-26 4:15 pm Purchase | 2024-11-22 | 13D | Verrica Pharmaceuticals Inc. VRCA | Manning Paul B | 5,250,405 49.900% | 3,711,457 (+241.17%) | Filing |
| 2022-07-15 4:15 pm Purchase | 2022-07-05 | 13D | Verrica Pharmaceuticals Inc. VRCA | Manning Paul B | 1,538,948 37.400% | 476,190 (+44.81%) | Filing |
| 2022-02-14 4:37 pm Purchase | 2021-12-31 | 13G | Verrica Pharmaceuticals Inc. VRCA | Manning Paul B | 1,062,758 38.600% | 78,983 (+8.03%) | Filing |
| 2021-02-16 4:04 pm Purchase | 2020-12-31 | 13G | Verrica Pharmaceuticals Inc. VRCA | Manning Paul B | 983,775 38.000% | 19,450 (+2.02%) | Filing |